KDM1A and cancer: LSD1 overexpression conferred resistance both to MCF-7 (Figure 1F) and MDA-MB-468 cells (Figure 1G) against doxorubicin-induced death, leading to a significant increase in the percentage of cancer cells that survived after drug treatment.